Akers Biosciences shareholders elect new directors
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Akers Biosciences Inc. shareholders elected Bill White, Richard Tarbox III and Christopher Schreiber to the company's board.
The company said former Nonexecutive Chairman Thomas Knox, along with nonexecutive directors Robert Andrews, Brandon Knox and Raza Bokhari, did not stand for re-election.
